Triamterene and Hydrochlorothiazide
- Product NDC
- 0527-1632
- 11-digit product format
- 005271632
- Labeler code
- 0527
- Product ID
- 0527-1632_4d422902-e50b-4596-a753-5d5a9b29b209
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Triamterene and Hydrochlorothiazide
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Lannett Company, Inc.
- Application
- ANDA201407
- Marketing category
- ANDA
- Marketing start
- 2011-12-09
- Marketing end
- 0000-00-00
- Substance
- HYDROCHLOROTHIAZIDE; TRIAMTERENE
- Active strength
- 25 mg/1; mg/1
- Pharmacologic classes
- Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0527-1632-01 | Triamterene and Hydrochlorothiazide | 100 in 1 BOTTLE | CAPSULE | 100 | | 15 |
| 0527-1632-10 | Triamterene and Hydrochlorothiazide | 1000 in 1 BOTTLE | CAPSULE | 1000 | | 15 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| HYDROCHLOROTHIAZIDE | ACTIVE INGREDIENT | 0J48LPH2TH | TRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [LANNETT COMPANY, INC.] | 8 | |
| TRIAMTERENE | ACTIVE INGREDIENT | WS821Z52LQ | TRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [LANNETT COMPANY, INC.] | 8 | |
| HYDROCHLOROTHIAZIDE | ACTIVE MOIETY | 0J48LPH2TH | TRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [LANNETT COMPANY, INC.] | 8 | |
| TRIAMTERENE | ACTIVE MOIETY | WS821Z52LQ | TRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [LANNETT COMPANY, INC.] | 8 | |
| ALCOHOL | INACTIVE INGREDIENT | 3K9958V90M | TRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [LANNETT COMPANY, INC.] | 8 | |
| ALUMINUM OXIDE | INACTIVE INGREDIENT | LMI26O6933 | TRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [LANNETT COMPANY, INC.] | 8 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | TRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [LANNETT COMPANY, INC.] | 8 | |
| BUTYL ALCOHOL | INACTIVE INGREDIENT | 8PJ61P6TS3 | TRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [LANNETT COMPANY, INC.] | 8 | |
| D&C YELLOW NO. 10 | INACTIVE INGREDIENT | 35SW5USQ3G | TRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [LANNETT COMPANY, INC.] | 8 | |
| FD&C BLUE NO. 1 | INACTIVE INGREDIENT | H3R47K3TBD | TRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [LANNETT COMPANY, INC.] | 8 | |
| FD&C BLUE NO. 2 | INACTIVE INGREDIENT | L06K8R7DQK | TRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [LANNETT COMPANY, INC.] | 8 | |
| FD&C RED NO. 40 | INACTIVE INGREDIENT | WZB9127XOA | TRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [LANNETT COMPANY, INC.] | 8 | |
| FERROSOFERRIC OXIDE | INACTIVE INGREDIENT | XM0M87F357 | TRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [LANNETT COMPANY, INC.] | 8 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | TRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [LANNETT COMPANY, INC.] | 8 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | TRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [LANNETT COMPANY, INC.] | 8 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | TRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [LANNETT COMPANY, INC.] | 8 | |
| METHYL ALCOHOL | INACTIVE INGREDIENT | Y4S76JWI15 | TRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [LANNETT COMPANY, INC.] | 8 | |
| POLYSORBATE 80 | INACTIVE INGREDIENT | 6OZP39ZG8H | TRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [LANNETT COMPANY, INC.] | 8 | |
| POVIDONE | INACTIVE INGREDIENT | FZ989GH94E | TRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [LANNETT COMPANY, INC.] | 8 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | TRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [LANNETT COMPANY, INC.] | 8 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | TRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [LANNETT COMPANY, INC.] | 8 | |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | INACTIVE INGREDIENT | 5856J3G2A2 | TRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [LANNETT COMPANY, INC.] | 8 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | TRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [LANNETT COMPANY, INC.] | 8 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | TRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [LANNETT COMPANY, INC.] | 8 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0527-1632 | TRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [LANNETT COMPANY, INC.] | 15 | Legacy NDC, 2 package rows | 20220729_b23d4978-0d47-457a-8176-0e8c567d5dd1.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0527-1632-01 | 00527163201 | 100 CAPSULE in 1 BOTTLE (0527-1632-01) | 100 capsule | 2011-12-09 | 0000-00-00 | No | No | Current |
| 0527-1632-10 | 00527163210 | 1000 CAPSULE in 1 BOTTLE (0527-1632-10) | 1000 capsule | 2011-12-09 | 0000-00-00 | No | No | Current |